Tag: Pharmaceutical

These Could Be the Best-Performing Pharmaceutical Stocks Through 2030

The pharmaceutical industry isn’t the first place investors turn to when looking for high-growth stocks. However, some companies in the field look so promising that they could deliver well-above-average returns through the end of the decade. There are several candidates here, but two of the most attractive today are Eli Lilly (NYSE: LLY) and Novo […]

1 Unstoppable Pharmaceutical Stock Investors Shouldn’t Sleep On

One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound have become staples for treating diabetes and obesity. Eli Lilly (NYSE: LLY) is the developer of Mounjaro and Zepbound, two popular medications used to treat those conditions. The main […]

German pharmaceutical firm Merck lays cornerstone for research centre

The time capsule for the laying of the foundation stone is ready. The pharmaceutical and chemical company Merck is investing more than 300 million euros in a new research center at its headquarters in Darmstadt. Andreas Arnold/dpa German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research […]

3 Pharmaceutical Stocks to Buy Hand Over Fist in March

Pharmaceutical companies play a tremendous role in modern healthcare. While sometimes controversial, drugmakers design medicine to treat some of the worst ailments plaguing society and constantly innovate to improve human life. Their long-term relevance in healthcare makes the pharmaceutical business an excellent place for investors to find long-term investment ideas. These three stocks offer investors […]

UPDATE 2-Teva to divest active pharmaceutical ingredient business

(Adds share movement in paragraph 3, background throughout) Jan 31 (Reuters) – Teva Pharmaceutical Industries will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world’s largest generic drugs maker said on Wednesday. The API unit, which brought in revenue of $1.05 billion in 2022, makes pharmaceutical ingredients that are […]

After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here’s Why I’m Probably Wrong

Artificial intelligence (AI) wasn’t the only big investment theme last year. The pharmaceutical industry saw increased interest due to the popularity of new weight-monitoring treatments. In particular, Danish drug manufacturer Novo Nordisk (NYSE: NVO) enjoyed tailwinds fueled by demand over its flagship products Ozempic, Wegovy, Rybelsus, and Saxenda. The stock’s 53% return handily topped the […]